Noriday

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Noriday

Property Description
Active ingredient Norethisterone (Norethindrone)
Form Oral Tablet
Pharmacological class Synthetic Progestin
Common use Contraception (Pregnancy Prevention)
Origin Synthetic (Steroid derivative)

1. What Type of Contraceptive is Noriday?

Noriday is a specific prescription-only medicine (POM) categorized as a Progestogen-Only Pill (POP), commonly known as the mini-pill, whose sole purpose is the reliable prevention of pregnancy. This medicine belongs to the hormonal contraceptive class, which is clinically recognized for its effectiveness when used consistently. Noriday is notably estrogen-free, distinguishing it from combined pills. This single-hormone composition provides a suitable contraceptive option for women who cannot take or are advised against estrogen-containing products.

2. Composition and Origin: Norethisterone and its Unique Positioning

The core active pharmaceutical ingredient in Noriday is Norethisterone (INN: Norethindrone), which is a synthetic progestin derived from testosterone. It is classified as a C19 steroid. This chemical origin means it is a manufactured substance designed to functionally mimic the effects of the natural hormone progesterone. Noriday is supplied as a single-ingredient oral tablet, containing only Norethisterone as its active component, a common feature among products specifically positioned for patients seeking estrogen avoidance.

3. Understanding the General Purpose of the Progestin-Only Pill

The general therapeutic purpose of Noriday is to establish hormonal conditions that prevent conception, a benefit consistently observed in clinical practice. This is achieved by the Norethisterone modifying the female reproductive environment. This class of progestins primarily acts by increasing the viscosity of the cervical mucus, creating a physical impediment to sperm transit, and concurrently inducing changes in the endometrial lining, making the uterus less receptive to the implantation of a fertilized egg. This summary highlights that the medicine's function provides effective, continuous contraceptive protection.

Regulatory References

  1. Progestins - StatPearls - NCBI Bookshelf

What side effects are possible with Noriday?

Possible side effects and safety information

This section outlines the officially documented adverse effects and safety constraints for Noriday (norethisterone), based strictly on governmental regulatory prescribing information (e.g., FDA, TGA). It is not clinical advice.

Frequency-Classified Adverse Reactions

The most frequently reported effects relate to changes in the menstrual cycle, often becoming apparent during the initial months of use. Common adverse reactions include:

  • Reproductive System: Menstrual irregularities, including spotting, irregular bleeding, or amenorrhea (absence of periods).
  • Nervous System: Headache and dizziness.
  • Other: Breast tenderness, nausea, acne, hirsutism (excessive hair growth), and weight gain.

Less common side effects documented in official labeling include long bleeding episodes and, rarely, certain androgenic effects and benign hepatic adenomas.

Serious Adverse Reactions and Safety Constraints

Official regulatory documents note that Noriday carries a potential risk of serious adverse reactions, though they are uncommon. These documented risks include:

  • Thromboembolic Events (Blood clots).
  • Ectopic Pregnancy (Extrauterine pregnancy).
  • Hepatic Neoplasia (Liver tumors).

Safety Restrictions and Contraindications:

Use of this medicine is strictly contraindicated in specific situations as defined by regulatory labeling, including known or suspected pregnancy, history of carcinoma of the breast, and presence of active liver disease or liver tumors. The labeling also explicitly states that the medicine does not protect against HIV infection (AIDS) or other sexually transmitted diseases.

Overdose and Emergency Response

Noriday Overdose and When to Seek Help

The official regulatory profile for Noriday (norethindrone) addresses overdosage but indicates that no serious ill effects have been reported following the ingestion of large doses of this type of oral contraceptive. This classification is the core of the official guidance regarding overdose situations.

Documented Overdose Symptoms

Symptoms that may occur following an overdose are generally limited to those affecting the gastrointestinal and reproductive systems:

  • Nausea and Vomiting: Gastrointestinal upset is the most common manifestation reported.
  • Vaginal Bleeding: Withdrawal bleeding may occur in females who have taken a dose higher than prescribed.
  • Population-Specific Note: In girls who have not yet reached puberty (pre-menarcheal), vaginal bleeding has been noted as a possible symptom.

Emergency Response Guidance

Given the nature of the documented overdose profile, official documentation specifies that treatment should primarily consist of symptomatic support. There is no official requirement for immediate, urgent medical attention based solely on the severity of these expected overdose symptoms, as they are described as not serious. However, as with any suspected overdose or ingestion of a high dose, the most appropriate course of action is to contact a healthcare provider or a poison control center for individualized advice. If an individual experiences any symptoms that are severe, persistent, or cause significant concern, emergency medical services should be contacted without delay.

Therapeutic Uses of Noriday

What Noriday Treats: Main Uses and Benefits

Noriday is a Progestogen-Only Pill (POP) whose therapeutic focus is strictly on providing continuous hormonal support for pregnancy prevention. It is commonly used to help manage fertility status and contributes to providing supportive, long-term contraceptive benefits. Its core indication is based on clinical product information.


Contraceptive Support and Estrogen Avoidance

Noriday is used for managing the clinical situation of active fertility, which is the physiological status that requires management. Its primary use involves continuous prevention of pregnancy and providing a relevant contraceptive choice in cases requiring an estrogen-free hormonal regimen. It is relevant in clinical settings where patients are medically advised to use progestogen-only options.

“It is used for managing symptoms related to the fear of unintended conception and provides continuous support against this risk.”

The medication is commonly used to address conditions characterized by the need for ongoing contraceptive control, specifically supporting patients who must avoid estrogen, and those in the postpartum phase. This assists with maintaining a sense of stability while supporting the patient's family planning goals.


Quick Fact: Relief for Unintended Conception Risk The medication is relevant for easing the overall symptom burden by providing supportive relief in the domain of reproductive health and assists with maintaining functional stability in long-term family planning.

Eligibility and Restrictions for Use

Noriday is an estrogen-free medicine intended for use by women of childbearing potential who require hormonal contraception.


Populations for Whom Use is Contraindicated

Official regulatory documents state that Noriday is contraindicated and must not be used by individuals with the following conditions:

  • Known or Suspected Pregnancy: The medicine is strictly prohibited throughout all trimesters.
  • Sex-Steroid Sensitive Malignancy: This includes current or past history of breast cancer or other hormone-dependent cancers of the sex organs.
  • Severe Hepatic Disease or Tumors: Patients with acute or severe chronic liver disease, benign or malignant liver tumors, or a history of specific jaundice syndromes.
  • Thrombotic Disease: A history of thrombophlebitis, thromboembolic disorders, cerebral vascular disease, or severe arterial disease.
  • Undiagnosed Abnormal Genital Bleeding or known hypersensitivity to Norethisterone.

Age and Physiological Eligibility Status

Group Official Regulatory Status
Pregnancy Contraindicated
Lactation (Breastfeeding) Generally Permitted (considered suitable for use)
Pre-menarcheal Patients Not Indicated or applicable
Post-menopausal Older Adults Not Applicable (Contraception is not relevant)

Eligibility-Related Restrictions

Use requires caution and monitoring in patients with conditions such as diabetes mellitus, hypertension, a history of migraines, or specific risk factors for blood clots, such as being overweight or a smoker over age 35.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory documentation structures the interaction profile of this medicine based on the potential for reduced efficacy and altered exposure of co-administered drugs.

Documented Interacting Categories

Interactions primarily concern medicines that may significantly alter the concentration of the progestogen component, leading to reduced effectiveness. Conversely, this medicine may alter the therapeutic activity of certain co-administered drugs.

Interaction Type Examples of Interacting Categories/Substances
Reduced Effectiveness (Victim Drug) Anticonvulsants (e.g., Phenytoin, Carbamazepine), Anti-tuberculosis drugs (e.g., Rifampicin), Antibiotics (e.g., Tetracyclines), Herbal preparations (St John's wort).
Altered Effect of Co-Medication (Perpetrator Drug) Corticosteroids (e.g., Prednisolone), Anticoagulants, Cyclosporin.
Altered Absorption (Physical Separation Required) Antacids.

Regulatory Requirements for Interaction Management

Regulatory labeling outlines specific management requirements when co-administering these substances:

  • Enzyme-Inducing Medicines: Concomitant use with medicines known to induce drug-metabolising enzymes (like those for epilepsy or tuberculosis) is documented to increase the metabolism of the progestogen, potentially leading to a loss of contraceptive effect. An additional, non-hormonal contraceptive method must be used both during the co-treatment period and for a specified time after the interacting medicine is stopped.
  • Antacids: To ensure proper absorption, official documents state that antacids should be taken at least 2 hours apart from this medicine.
  • Other Medicines: Because this medicine may alter the effects of drugs such as anticoagulants and corticosteroids, monitoring and potential dose adjustment of the co-administered drug may be necessary, according to official guidance.

Mechanism of Action

Noriday contains norethisterone, a synthetic progestin that modulates three key biological systems. It functions as an agonist by binding to and activating progesterone receptors in target tissues. The drug's peripheral action occurs in the lower reproductive tract. Receptor activation in the cervix induces the glands to secrete dense, highly viscous mucus, which creates a physical barrier to sperm migration. Simultaneously, it modifies the endometrium (uterine lining) by causing premature maturation and atrophy, resulting in a thin, undeveloped state. Concurrently, the drug exerts a central mechanism by acting on the Hypothalamic-Pituitary-Ovarian (HPO) axis. Norethisterone engages a negative feedback loop that reduces the release of Luteinizing Hormone (LH) from the pituitary gland. This suppression partially inhibits the hormonal cascade required for follicular maturation and release of an egg. These concurrent peripheral and central effects constitute the complete mechanism of action.

Dosage and Administration Information

The standardized administration of Noriday requires the oral ingestion of one 0.35 mg tablet daily. This Progestogen-Only Pill (POP) is designated for continuous, long-term use for as long as contraceptive protection is desired, maintaining an uninterrupted schedule without a hormone-free interval. The tablet may be swallowed with water and is designated to be taken independent of meals.

A defining element of the usage protocol is the necessity to take the tablet at the same time every day. If the administration is delayed by more than three hours past the scheduled time, the established contraceptive pattern is interrupted. If this strict time-window is exceeded, the procedure involves taking the last missed tablet immediately and using an additional non-hormonal barrier method for the subsequent 48 hours. This procedural structure defines the high level of adherence required for the continuous use protocol. The continuous one-tablet daily dose applies equally to postmenarche adolescents. Furthermore, the timing for initiating the medication for postpartum women varies, with specific guidance based on whether they are breastfeeding or not.

Recent Clinical Evidence

Noriday: Recent Clinical Evidence

Recent research focusing on Noriday (norethisterone 350 micrograms) has centered on its use as a progestogen-only contraceptive. Studies continue to examine its effectiveness and safety profile, particularly in diverse patient populations, to inform clinical practice and guidance.

Contraceptive Effectiveness

Clinical trials have established the primary role of norethisterone in pregnancy prevention. Its mechanism relies mainly on thickening cervical mucus, which impedes sperm passage, and to a lesser extent, on inhibiting ovulation. Data consistently indicate that, when taken correctly and consistently, Noriday provides a high level of protection against pregnancy.

Primary Efficacy Mechanism Secondary Efficacy Mechanism
Thickening of cervical mucus Suppression of ovulation (variable)

Tolerability and Bleeding Patterns

Research has specifically tracked common side effects and their impact on adherence. Changes in menstrual bleeding patterns are the most frequently reported issue associated with progestogen-only pills like Noriday. These changes may include irregular bleeding, spotting, or amenorrhea (absence of bleeding). Ongoing studies aim to clarify the predictability of these bleeding changes across different cycles.

Safety in Specific Groups

Recent investigations support the use of Noriday in groups where combined hormonal contraceptives may be contraindicated, such as breastfeeding women or those with certain cardiovascular risk factors. These studies primarily evaluate the compound's impact on lactation and its general metabolic and thrombotic safety profile in these specific populations.

Overall, the evidence confirms the well-established efficacy and tolerability profile of Noriday as an important option within the range of available hormonal contraceptives, particularly for those requiring an estrogen-free method.

Key Studies & References

  1. NORIDAY® 28 DAY 0.35 mg tablets - NEW ZEALAND DATA SHEET (Mechanism, Bleeding Patterns, Contraindications)
  2. Progestin-Only (norethindrone) Oral Contraceptives: MedlinePlus Drug Information (Overview, Mechanism, Side Effects)
  3. Medical eligibility criteria for contraceptive use - WHO (Guidance on use in specific populations like breastfeeding women)
  4. Oral Contraceptive Pills - StatPearls (General POP characteristics, efficacy comparison)

Frequently Asked Questions (FAQ)

Common questions about Noriday (FAQ)


Q: What is the main difference between Noriday and other birth control pills?

A: Noriday is known as a Progestogen-Only Pill (POP) or mini-pill, meaning it contains only a progestogen hormone and is notably estrogen-free. This single-hormone composition is the main difference from combined oral contraceptives, which contain both progestogen and estrogen. Official documents describe Noriday as a suitable option for women advised against estrogen-containing methods.


Q: Will Noriday cause my periods to stop entirely?

A: Changes in your menstrual bleeding pattern are very common while using Noriday. Official documentation lists amenorrhea, which is the complete absence of periods, as a reported adverse reaction. While it is a possible effect of continuous progestogen use, the outcome is not guaranteed for every individual.


Q: Is Noriday safe to take if I have high blood pressure?

A: Regulatory documents state that use requires caution and monitoring for individuals with hypertension (high blood pressure). Progestogen-only pills like this one may be considered for women who cannot take combined pills due to blood pressure concerns. Careful medical assessment may be required when considering use.


Q: Can Noriday be taken by women over the age of 35?

A: The medication can generally be used by women in this age group, particularly when combined hormonal contraceptives are contraindicated. Regulatory guidance specifies that certain risk factors, such as being a smoker over age 35, require caution and professional monitoring.


Q: Are there any long-term health risks associated with taking Noriday?

A: Official documents list a potential, though uncommon, risk of serious adverse reactions, including blood clots and liver tumors. The potential risk of breast cancer diagnosis is also noted in regulatory documentation.


Q: How does Noriday work differently than estrogen pills?

A: Noriday's primary mechanism relies on thickening the cervical mucus to block sperm from entering the womb and changing the uterine lining. While it can suppress ovulation, this effect is variable. Unlike combined pills, which typically function by consistently preventing the release of an egg (ovulation), Noriday's suppression of ovulation is variable.


Q: What are the most common reasons a doctor prescribes Noriday?

A: The main purpose is contraception. It is often prescribed for women who specifically require an estrogen-free method. This may include women who are breastfeeding or those who have medical conditions like high blood pressure or a history of migraines that make combined pills unsuitable.


Q: What is the general success rate of Noriday as described in research?

A: Studies indicate that Noriday provides a high level of protection when taken consistently and correctly (often cited at over 99%). Official research summaries note that the effectiveness rate in typical day-to-day use, which accounts for missed doses, is generally cited as being around 93%. This difference reflects the distinction between perfect use efficacy and typical use efficacy cited in research.


Q: What is Noriday used for besides contraception?

A: The 0.35 mg Noriday product is formally indicated only for contraception. However, the active ingredient, norethisterone, is used at significantly higher doses in other medications to address certain menstrual disorders, such as secondary amenorrhea (lack of a period).


Q: How quickly does Noriday start working?

A: If the pill is started on the first day of the menstrual cycle, contraceptive protection is generally considered to begin immediately. If initiated at any other time during the cycle, official guidance describes the necessity of using an additional non-hormonal barrier method for the first seven days.


Q: Can Noriday be used to regulate my period cycle?

A: The 0.35 mg Noriday product is not indicated for cycle regulation, and its use is commonly associated with side effects like irregular bleeding or spotting. Official documents confirm that the active ingredient is used in different, higher doses to treat specific menstrual disorders.


Q: Can Noriday affect mood or cause mood swings?

A: Yes, official documentation lists changes to mood, mood swings, and a depressed mood as documented possible side effects of this medication.


Q: Does Noriday interact with paracetamol or ibuprofen?

A: Official interaction databases generally do not report a direct interaction between Noriday (norethisterone 0.35 mg) and common over-the-counter pain relievers such as paracetamol (acetaminophen) or ibuprofen.


Q: How does Noriday compare to other progestogen-only pills in terms of effectiveness?

A: Noriday contains an older generation progestogen. Official studies confirm its effectiveness when used consistently, noting that its primary mechanisms differ from some newer progestogen-only formulations.


Q: What kind of studies have been done on the safety of Noriday?

A: The efficacy and safety profile of Noriday are supported by clinical trials, which examine its effectiveness and tolerability in patient groups. They are also supported by long-term epidemiological studies, which monitor the incidence of serious adverse events across large populations.


Q: Why are there different types of Noriday packaging?

A: The typical packaging for Noriday is a 28-day continuous-use pack. This packaging structure is aligned with the continuous regimen defined in the official prescribing information, which requires continuous daily administration without a hormone-free break.


Q: Does taking Noriday affect future fertility?

A: Regulatory guidance indicates that fertility returns immediately to its normal level once the use of Noriday has been discontinued.


Q: Can Noriday be used as emergency contraception?

A: Official product information explicitly states that Noriday is not intended for and will not work as emergency contraception (the morning-after pill).


Q: Does vomiting after taking the pill affect Noriday’s effectiveness?

A: Gastrointestinal upsets, such as vomiting or severe diarrhea, can interfere with the pill's absorption and potentially reduce its contraceptive efficacy. When this occurs, the official protocol outlines the necessity of using an additional non-hormonal barrier method for the subsequent seven days.


Q: Is it common to feel bloated when starting Noriday?

A: Official documentation lists abdominal pain, cramps, and bloating as documented possible side effects associated with the use of this medication.


Q: What happens to the body when you stop taking Noriday?

A: When the medication is discontinued, the body is expected to gradually return to its normal hormonal function. Official guidance states that fertility returns immediately, and a regular menstrual cycle is expected to return over time.


Q: Is Noriday a generic or brand-name drug?

A: Noriday is a specific brand name for the active ingredient norethisterone (0.35 mg). The medication is also available under the generic name norethindrone tablets (0.35 mg).


Q: Do people often report feeling tired when taking Noriday?

A: Tiredness and fatigue are listed in official documentation as possible adverse reactions associated with the use of this medication.


Q: Are there specific food items that interact with Noriday?

A: Regulatory documents describe a potential interaction with grapefruit and grapefruit juice, noting that these substances may increase the blood levels of the active ingredient (norethindrone).


Q: Do official documents mention any effects of Noriday on libido?

A: Official documentation lists changes in sex drive (libido) as a possible side effect associated with the use of this medication.


Q: What is the expected timeline for returning to a regular menstrual cycle after stopping Noriday?

A: While fertility generally returns immediately after stopping the medication, the expected timeline for the return of a regular menstrual cycle is variable. The time it takes can differ for each individual patient.


Q: Can I start Noriday at any point in my menstrual cycle?

A: Yes, Noriday can be started at any point in the menstrual cycle, provided that pregnancy has been ruled out. If initiation does not occur on the first day of the menstrual cycle, regulatory guidance specifies the necessity of using an additional non-hormonal barrier method for the first seven days.

How should Noriday be stored and disposed of?

How to Store and Dispose of Noriday

Official regulatory documents define strict environmental controls for Noriday tablets to maintain their stability and five-year shelf life.

Storage and Protection Requirement
Temperature Do not store above 25 C (Do not exceed 77 F).
Protection Must be kept in the original outer carton to protect the tablets from light and moisture.
Child Safety Store out of the sight and reach of children.

Disposal Requirements:

Unused or expired Noriday must not be disposed of via household waste, wastewater, or flushing. The medication must be returned to a pharmacist for appropriate disposal to ensure compliance with environmental protection regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Noriday found in:

A-Z Index: